Scancell Holdings plc SCLP.L Stock
Scancell Holdings plc Price Chart
Scancell Holdings plc SCLP.L Financial and Trading Overview
| Scancell Holdings plc stock price | 10.1 GBP |
| Previous Close | 11.13 GBP |
| Open | 10.86 GBP |
| Bid | 10.5 GBP x 0 |
| Ask | 12.5 GBP x 0 |
| Day's Range | 10.25 - 10.86 GBP |
| 52 Week Range | 7.59 - 27.4 GBP |
| Volume | 1.41M GBP |
| Avg. Volume | 851.11K GBP |
| Market Cap | 98.54M GBP |
| Beta (5Y Monthly) | 0.238 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 GBP |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 23.19 GBP |
SCLP.L Valuation Measures
| Enterprise Value | 90.72M GBP |
| Trailing P/E | N/A |
| Forward P/E | -5.9065933 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 18.695395 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 17.21 |
| Enterprise Value/EBITDA | -7.969 |
Trading Information
Scancell Holdings plc Stock Price History
| Beta (5Y Monthly) | 0.238 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 27.4 GBP |
| 52 Week Low | 7.59 GBP |
| 50-Day Moving Average | 12.85 GBP |
| 200-Day Moving Average | 13.62 GBP |
SCLP.L Share Statistics
| Avg. Volume (3 month) | 851.11K GBP |
| Avg. Daily Volume (10-Days) | 1.48M GBP |
| Shares Outstanding | 916.68M |
| Float | 439.16M |
| Short Ratio | N/A |
| % Held by Insiders | 5.78% |
| % Held by Institutions | 46.99% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 10:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | April 30, 2023 |
| Most Recent Quarter (mrq) | April 30, 2023 |
| Next Fiscal Year End | April 30, 2024 |
Profitability
| Profit Margin | -226.44% |
| Operating Margin (ttm) | -226.14% |
| Gross Margin | 90.03% |
| EBITDA Margin | -215.97% |
Management Effectiveness
| Return on Assets (ttm) | -21.66% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 5.27M GBP |
| Revenue Per Share (ttm) | 0.006 GBP |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -11384000 GBP |
| Net Income Avi to Common (ttm) | -11936000 GBP |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 19.92M GBP |
| Total Cash Per Share (mrq) | 0.02 GBP |
| Total Debt (mrq) | 19.53M GBP |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 7.511 |
| Book Value Per Share (mrq) | -0.008 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8140000 GBP |
| Levered Free Cash Flow (ttm) | -6998375 GBP |
Profile of Scancell Holdings plc
| Country | United Kingdom |
| State | N/A |
| City | Oxford |
| Address | Bellhouse Building |
| ZIP | OX4 4GD |
| Phone | 44 18 6558 2066 |
| Website | https://www.scancell.co.uk |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 51 |
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer. It also develops Modi-1, a citrullinated peptides vaccine that is in phase I/II clinical trials for the treatment of solid tumors including triple negative breast, ovarian, renal, and head and neck cancers; and Modi-2, which targets homocitrullinated cancer antigens. In addition, the company focuses to develop SCOV1 and SCOV2 COVIDITY, a DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.
Q&A For Scancell Holdings plc Stock
What is a current SCLP.L stock price?
Scancell Holdings plc SCLP.L stock price today per share is 10.1 GBP.
How to purchase Scancell Holdings plc stock?
You can buy SCLP.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Scancell Holdings plc?
The stock symbol or ticker of Scancell Holdings plc is SCLP.L.
Which industry does the Scancell Holdings plc company belong to?
The Scancell Holdings plc industry is Biotechnology.
How many shares does Scancell Holdings plc have in circulation?
The max supply of Scancell Holdings plc shares is 9.28M.
What is Scancell Holdings plc Price to Earnings Ratio (PE Ratio)?
Scancell Holdings plc PE Ratio is now.
What was Scancell Holdings plc earnings per share over the trailing 12 months (TTM)?
Scancell Holdings plc EPS is -0.01 GBP over the trailing 12 months.
Which sector does the Scancell Holdings plc company belong to?
The Scancell Holdings plc sector is Healthcare.
Scancell Holdings plc SCLP.L included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| FTSE AIM All-Share Index FTAI | 755.91 GBP 966.76 USD |
-0.38
|
— — | 755.91 GBP 966.76 USD | 763.17 GBP 976.05 USD | — - | — — |
- {{ link.label }} {{link}}